Membrane-protein (GPCR) targeted drug discovery (antibodies, ADCs)
| Date | Round | Amount |
|---|---|---|
| Aug 2024 | Funding round LiberoThera, a membrane-protein (GPCR) drug-discovery company, raised 720M JPY from Taiho Ventures, MP Healthcare Venture Management and UTokyo IPC. | $4.8M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.